Coherus Oncology (CHRS) Operating Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) Operating Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Coherus Oncology | 221.39 Mn | 116.08 Mn | 10.07 Mn | 21,761.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,761.00 |
| Mar 31, 2026 | 30,424.00 |
| Dec 31, 2025 | 22,699.00 |
| Sep 30, 2025 | 39,108.00 |
| Jun 30, 2025 | -5,872.00 |
| Mar 31, 2025 | 233,914.00 |
| Dec 31, 2024 | -51,160.00 |
| Sep 30, 2024 | -73,130.00 |
| Jun 30, 2024 | -32,604.00 |
| Mar 31, 2024 | -272,819.00 |
| Dec 31, 2023 | 3,825.00 |
| Sep 30, 2023 | 13,418.00 |
| Jun 30, 2023 | 1,434.00 |
| Mar 31, 2023 | -7,424.00 |
| Dec 31, 2022 | -5,963.00 |
| Sep 30, 2022 | -13,736.00 |
| Jun 30, 2022 | -4,560.00 |
| Mar 31, 2022 | 6,694.00 |
| Dec 31, 2021 | -6,879.00 |
| Sep 30, 2021 | -6,943.00 |